Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Enterprise Value : 783.79M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 783.79M |
| November 12, 2026 | 791.82M |
| November 11, 2026 | 854.99M |
| November 10, 2026 | 890.32M |
| November 09, 2026 | 887.91M |
| November 06, 2026 | 865.16M |
| November 05, 2026 | 805.74M |
| November 04, 2026 | 836.25M |
| November 03, 2026 | 795.57M |
| November 02, 2026 | 785.40M |
| October 30, 2026 | 763.45M |
| October 29, 2026 | 843.75M |
| October 28, 2026 | 805.21M |
| October 27, 2026 | 853.38M |
| October 26, 2026 | 829.29M |
| October 23, 2026 | 817.52M |
| October 22, 2026 | 825.55M |
| October 21, 2026 | 770.41M |
| October 20, 2026 | 746.32M |
| October 19, 2026 | 666.56M |
| October 16, 2026 | 668.70M |
| October 15, 2026 | 656.39M |
| October 14, 2026 | 607.14M |
| October 13, 2026 | 575.02M |
| October 12, 2026 | 632.30M |
| Date | Value |
|---|---|
| October 09, 2026 | 685.83M |
| October 08, 2026 | 672.98M |
| October 07, 2026 | 674.06M |
| October 06, 2026 | 644.08M |
| October 05, 2026 | 704.57M |
| October 02, 2026 | 700.29M |
| October 01, 2026 | 728.66M |
| September 30, 2026 | 793.96M |
| September 29, 2026 | 732.19M |
| September 28, 2026 | 783.05M |
| September 25, 2026 | 883.69M |
| September 24, 2026 | 862.27M |
| September 23, 2026 | 871.37M |
| September 22, 2026 | 930.26M |
| September 21, 2026 | 862.27M |
| September 18, 2026 | 876.73M |
| September 17, 2026 | 899.74M |
| September 16, 2026 | 916.87M |
| September 15, 2026 | 960.77M |
| September 14, 2026 | 1.054B |
| September 11, 2026 | 981.11M |
| September 10, 2026 | 977.90M |
| September 09, 2026 | 896.00M |
| September 08, 2026 | 1.020B |
| September 04, 2026 | 1.062B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 715.26B |
| Bristol Myers Squibb Co. | 161.88B |
| Harmony Biosciences Holdings, Inc. | 1.444B |
| ANI Pharmaceuticals, Inc. | 1.807B |
| Corcept Therapeutics, Inc. | 7.615B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.39M |
| Total Expenses (Quarterly) | 26.39M |
| EPS Diluted (Quarterly) | -0.4931 |
| Earnings Yield | -12.95% |
| Normalized Earnings Yield | -12.95 |